Swissquote Bank AG Share Price

Certificat

AAXESQ

CH1256124897

Market Closed - Swiss Exchange 16:20:00 27/05/2024 BST
101.8 CHF +0.13% Intraday chart for Swissquote Bank AG
Current month+1.38%
1 month+2.78%
Date Price Change
27/05/24 101.8 +0.13%
24/05/24 101.7 +0.03%
23/05/24 101.6 +0.06%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Swissquote Bank
AAXESQ
ISINCH1256124897
Date issued 22/09/2023
Strike 249.4 CHF
Maturity 23/09/2024 (116 Days)
Parity 0.25 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 101.8 CHF
Lowest since issue 84.31 CHF
Spread 8.2 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
228.3 CHF
Average target price
277.5 CHF
Spread / Average Target
+21.56%
Consensus
  1. Stock Market
  2. Certificates
  3. AAXESQ Certificat